White Papers
Free, practical decision frameworks and briefs — built around real commercial decisions, not to summarize reports. Emailed to you as a PDF.
Showing 1–6 of 8 white papers · newest first
Selecting an AI-Native Drug Discovery Platform: A Five-Dimension Evaluation Framework for Pharma R&D & BD Teams
AI drug discovery platforms now span foundation models, generative chemistry and lab-in-the-loop engines — with claims that are hard to compare. This white paper gives pharma R&D and BD teams a five-dimension framework to evaluate any platform on what actually predicts discovery success.
For: Strategy, R&D, Business Development, Portfolio, Innovation and Digital Transformation teams in pharma and biotech — and investors assessing AI drug discovery assets.
Read more →Securing GLP-1 & Peptide Manufacturing Capacity: A Sourcing and Risk Framework for Sponsors and Investors
A structured way to secure GLP-1 and peptide manufacturing capacity — assessing CDMO options, build-versus-reserve trade-offs and supply risk before demand outruns available supply.
For: Manufacturing Strategy, Supply Chain & Business Development teams in pharma and biotech — and investors assessing supply risk.
Read more →Biopharma Digital Infrastructure: Mapping AI Workloads to Compute, Data, Cloud & Software Requirements
A map of the principal biopharma AI workload categories to their compute, data, cloud and software requirements and buying centers.
For: Strategy & Technology teams selling into biopharma.
Read more →Commercializing Clinical AI: A Build-Buy-Partner Framework for Medical Device & Healthcare Technology Companies
A build-buy-partner decision framework grounded in clinical workflow fit, data access, regulatory position and commercial channel strength.
For: Corporate Development & Product teams in medtech and healthcare technology.
Read more →Veterinary mRNA Vaccines: Commercial Readiness, Manufacturing Strategy & Adoption Pathways
An assessment of the commercial readiness of veterinary mRNA platforms, the manufacturing choices facing developers, and the adoption pathways most likely to succeed by species and geography.
For: Animal Health Business Development & Portfolio teams.
Read more →The Transition to 800 V HVDC in AI Data Centers: Architecture Choices, Supplier Implications & Adoption Scenarios
How the shift to 800 V HVDC changes the data-center power value chain: architecture choices, the migration path, and what adoption scenarios mean for suppliers.
For: Strategy, Product & Investment teams across the data-center power value chain.
Read more →